101 related articles for article (PubMed ID: 8280707)
1. Recombinant vaccinia interleukin-2-infected tumor cell vaccines in immunotherapy of murine colon adenocarcinoma.
Bash JA
J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):269-72. PubMed ID: 8280707
[TBL] [Abstract][Full Text] [Related]
2. Colon cancer cell vaccine prepared with replication-deficient vaccinia viruses encoding B7.1 and interleukin-2 induce antitumor response in syngeneic mice.
Sivanandham M; Shaw P; Bernik SF; Paoletti E; Wallack MK
Cancer Immunol Immunother; 1998 Jul; 46(5):261-7. PubMed ID: 9690454
[TBL] [Abstract][Full Text] [Related]
3. Active specific immunotherapy of murine colon adenocarcinoma with recombinant vaccinia/interleukin-2-infected tumor cell vaccines.
Bash JA
Ann N Y Acad Sci; 1993 Aug; 690():331-3. PubMed ID: 8368746
[No Abstract] [Full Text] [Related]
4. Immunotherapy of a vaccinia colon oncolysate prepared with interleukin-2 gene-encoded vaccinia virus and interferon-alpha increases the survival of mice bearing syngeneic colon adenocarcinoma.
Tanaka N; Sivanandham M; Wallack MK
J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):283-93. PubMed ID: 7881637
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model.
Sivanandham M; Scoggin SD; Tanaka N; Wallack MK
Cancer Immunol Immunother; 1994 Apr; 38(4):259-64. PubMed ID: 8168121
[TBL] [Abstract][Full Text] [Related]
6. Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2.
McLaughlin JP; Schlom J; Kantor JA; Greiner JW
Cancer Res; 1996 May; 56(10):2361-7. PubMed ID: 8625312
[TBL] [Abstract][Full Text] [Related]
7. Induction of anti-tumor immunity elicited by tumor cells expressing a murine LFA-3 analog via a recombinant vaccinia virus.
Lorenz MG; Kantor JA; Schlom J; Hodge JW
Hum Gene Ther; 1999 Mar; 10(4):623-31. PubMed ID: 10094205
[TBL] [Abstract][Full Text] [Related]
8. Recombinant vaccinia expressing interleukin-2 for cancer gene therapy.
Qin H; Chatterjee SK
Cancer Gene Ther; 1996; 3(3):163-7. PubMed ID: 8725880
[TBL] [Abstract][Full Text] [Related]
9. A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model.
Jack AM; Aydin N; Montenegro G; Alam K; Wallack M
J Surg Res; 2007 May; 139(2):164-9. PubMed ID: 17275030
[TBL] [Abstract][Full Text] [Related]
10. Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSF.
Qin H; Chatterjee SK
Hum Gene Ther; 1996 Oct; 7(15):1853-60. PubMed ID: 8894677
[TBL] [Abstract][Full Text] [Related]
11. Construction and characterization of a recombinant vaccinia virus expressing murine intercellular adhesion molecule-1: induction and potentiation of antitumor responses.
Uzendoski K; Kantor JA; Abrams SI; Schlom J; Hodge JW
Hum Gene Ther; 1997 May; 8(7):851-60. PubMed ID: 9143911
[TBL] [Abstract][Full Text] [Related]
12. Insertion of interleukin-2 (IL-2) and interleukin-12 (IL-12) genes into vaccinia virus results in effective anti-tumor responses without toxicity.
Kaufman HL; Flanagan K; Lee CS; Perretta DJ; Horig H
Vaccine; 2002 Mar; 20(13-14):1862-9. PubMed ID: 11906776
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model.
Kaufman HL; Rao JB; Irvine KR; Bronte V; Rosenberg SA; Restifo NP
J Immunother; 1999 Nov; 22(6):489-96. PubMed ID: 10570747
[TBL] [Abstract][Full Text] [Related]
14. Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma.
Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
Mol Ther; 2006 Jan; 13(1):183-93. PubMed ID: 16125469
[TBL] [Abstract][Full Text] [Related]
15. A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA).
Kaufman H; Schlom J; Kantor J
Int J Cancer; 1991 Jul; 48(6):900-7. PubMed ID: 1860736
[TBL] [Abstract][Full Text] [Related]
16. Construction and characterization of a triple-recombinant vaccinia virus encoding B7-1, interleukin 12, and a model tumor antigen.
Carroll MW; Overwijk WW; Surman DR; Tsung K; Moss B; Restifo NP
J Natl Cancer Inst; 1998 Dec; 90(24):1881-7. PubMed ID: 9862625
[TBL] [Abstract][Full Text] [Related]
17. Treatment of murine hepatic metastases with vaccinia colon oncolysates and IL-2.
Barnavon Y; Iwaki H; Bash JA; Brettschneider F; Hilsenbeck S; Darnell E; Wallack MK
J Surg Res; 1988 Dec; 45(6):523-30. PubMed ID: 3263545
[TBL] [Abstract][Full Text] [Related]
18. Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen.
Wang M; Bronte V; Chen PW; Gritz L; Panicali D; Rosenberg SA; Restifo NP
J Immunol; 1995 May; 154(9):4685-92. PubMed ID: 7722321
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor immunity elicited by a recombinant vaccinia virus expressing CD70 (CD27L).
Lorenz MG; Kantor JA; Schlom J; Hodge JW
Hum Gene Ther; 1999 May; 10(7):1095-103. PubMed ID: 10340542
[TBL] [Abstract][Full Text] [Related]
20. Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection.
Ramshaw IA; Andrew ME; Phillips SM; Boyle DB; Coupar BE
Nature; 1987 Oct 8-14; 329(6139):545-6. PubMed ID: 3498904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
